| scholarly article | Q13442814 |
| P356 | DOI | 10.1371/JOURNAL.PONE.0181182 |
| P8608 | Fatcat ID | release_gtdcquti4besjkkjpo6lmib3pe |
| P932 | PMC publication ID | 5521781 |
| P698 | PubMed publication ID | 28732070 |
| P50 | author | Lin J Cai | Q80816186 |
| Chunlai Jiang | Q88576580 | ||
| P2093 | author name string | Yan Zhou | |
| Wei Kong | |||
| Bo Sun | |||
| Lu Bai | |||
| Fei Xu | |||
| Bin Fu | |||
| Dawei Liu | |||
| Yongge Wu | |||
| Dandan Zhao | |||
| Ali Hou | |||
| Shiyang Sun | |||
| Weiheng Su | |||
| Yanfei Chu | |||
| Youlei Ma | |||
| Chuntian Liu | |||
| P2860 | cites work | Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16 | Q57096427 |
| Evaluation of the stability of enterovirus 71 virus-like particle | Q39076793 | ||
| Identification and characterization of a cross-neutralization epitope of Enterovirus 71. | Q39556922 | ||
| Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group | Q40614108 | ||
| Comparisons of the glycosylation of a monoclonal antibody produced under nominally identical cell culture conditions in two different bioreactors | Q40876435 | ||
| N-Linked glycosylation of a baculovirus-expressed recombinant glycoprotein in insect larvae and tissue culture cells | Q41035528 | ||
| A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice | Q42211021 | ||
| Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. | Q44079611 | ||
| Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. | Q44201038 | ||
| Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles | Q45359895 | ||
| Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens inCervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine | Q45372298 | ||
| Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge | Q45396589 | ||
| Stabilization of human papillomavirus virus-like particles by non-ionic surfactants | Q45455736 | ||
| Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus | Q45734536 | ||
| Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach. | Q50782689 | ||
| The enterovirus 71 epidemic in 2008--public health implications for Hong Kong. | Q51147793 | ||
| Catching a Virus in the Act of RNA Release: a Novel Poliovirus Uncoating Intermediate Characterized by Cryo-Electron Microscopy | Q27660039 | ||
| A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71 | Q27677825 | ||
| Structures of the Procapsid and Mature Virion of Enterovirus 71 Strain 1095 | Q27677960 | ||
| MALDI-TOF mass spectrometry tools for bacterial identification in clinical microbiology laboratory | Q33629770 | ||
| Clinical and epidemiological characteristics of adult hand, foot, and mouth disease in northern Zhejiang, China, May 2008-November 2013. | Q33634281 | ||
| Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice | Q33723474 | ||
| Expression, purification and characterization of enterovirus-71 virus-like particles | Q33788579 | ||
| Cryo-electron microscopy study of insect cell-expressed enterovirus 71 and coxsackievirus a16 virus-like particles provides a structural basis for vaccine development | Q33887710 | ||
| An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China | Q33911890 | ||
| Incorporating significant amino acid pairs to identify O-linked glycosylation sites on transmembrane proteins and non-transmembrane proteins | Q34341576 | ||
| Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial | Q34347924 | ||
| An overview of the evolution of enterovirus 71 and its clinical and public health significance | Q34635602 | ||
| Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design | Q35055458 | ||
| Epidemiological analysis, detection, and comparison of space-time patterns of Beijing hand-foot-mouth disease (2008-2012). | Q35129310 | ||
| Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease. | Q35760496 | ||
| An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. | Q35948053 | ||
| Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice | Q36256455 | ||
| Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity. | Q36281860 | ||
| Progress on the research and development of inactivated EV71 whole-virus vaccines | Q37530094 | ||
| Virology, epidemiology, pathogenesis, and control of enterovirus 71. | Q37801742 | ||
| The virology and developments toward control of human enterovirus 71. | Q37886179 | ||
| Protein glycosylation control in mammalian cell culture: past precedents and contemporary prospects | Q37947967 | ||
| Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present | Q38024637 | ||
| Glycosylation: impact, control and improvement during therapeutic protein production. | Q38126913 | ||
| The influence of glycosylation on secretion, stability, and immunogenicity of recombinant HBV pre-S antigen synthesized in Saccharomyces cerevisiae | Q38520759 | ||
| Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice | Q38845816 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0181182 | |
| P577 | publication date | 2017-07-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Characterization of human enterovirus71 virus-like particles used for vaccine antigens | |
| P478 | volume | 12 |
Search more.